1-20 of 66
Authors: Isabel Arrillaga-Romany
Save search
Sort by
Journal Article

CTNI-60. SAFETY LEAD-IN RESULTS FOR QBS10072S IN THE INDIVIDUAL SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGHT) TRIAL, A RANDOMIZED ADAPTIVE PLATFORM TRIAL FOR NEWLY DIAGNOSED MGMT UNMETHYLATED GLIOBLASTOMA

PDF
Rifaquat Rahman and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii110, https://doi.org/10.1093/neuonc/noae165.0427
Published: 11 November 2024
Journal Article

DDDR-24. REAL WORLD EXPERIENCE USING THE IDH INHIBITOR IVOSIDENIB IN IDH MUTANT GLIOMA: TOLERABILITY AND OUTCOMES

PDF
Tyler Lanman and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii130–viii131, https://doi.org/10.1093/neuonc/noae165.0509
Published: 11 November 2024
Journal Article

CTIM-19. A PHASE 1, SAFETY LEAD-IN AND RANDOMIZED, OPEN-LABEL, PERIOPERATIVE STUDY OF VORASIDENIB COMBINED WITH PEMBROLIZUMAB IN RECURRENT OR PROGRESSIVE ENHANCING IDH-1 MUTANT GLIOMA: TRIAL IN PROGRESS

PDF
Patrick Wen and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii89, https://doi.org/10.1093/neuonc/noae165.0352
Published: 11 November 2024
Journal Article

EPCO-20. MUTANT IDH INHIBITORS INDUCE LINEAGE DIFFERENTIATION IN IDH-MUTANT OLIGODENDROGLIOMA

PDF
Avishay Spitzer and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii5, https://doi.org/10.1093/neuonc/noae165.0019
Published: 11 November 2024
Journal Article

CTNI-47. A PHASE 1, RANDOMIZED, PERIOPERATIVE TRIAL OF VORASIDENIB AND IVOSIDENIB IN IDH1-MUTANT DIFFUSE GLIOMA: UPDATED RESULTS

PDF
Ingo Mellinghoff and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii107, https://doi.org/10.1093/neuonc/noae165.0414
Published: 11 November 2024
Journal Article

CTNI-54. RESPONSE BY RANO2.0 CRITERIA IN ONC201 (DORDAVIPRONE)-TREATED PATIENTS WITH RECURRENT H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA

PDF
Timothy Cloughesy and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii109, https://doi.org/10.1093/neuonc/noae165.0421
Published: 11 November 2024
Journal Article

CTIM-28. NEOADJUVANT ANTI-PD1 IMMUNOTHERAPY FOR SURGICALLY ACCESSIBLE RECURRENT GLIOBLASTOMA: CLINICAL AND MOLECULAR OUTCOMES OF A STAGE 2 SINGLE-ARM EXPANSION COHORT

PDF
J Ricardo McFaline-Figueroa and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii92, https://doi.org/10.1093/neuonc/noae165.0361
Published: 11 November 2024
Journal Article

Demonstrated efficacy and mechanisms of sensitivity of ONC201: H3K27M-mutant diffuse midline glioma in the spotlight

PDF
Isabel Arrillaga-Romany and Julie J Miller
Neuro-Oncology, Volume 26, Issue 6, June 2024, Pages 991–992, https://doi.org/10.1093/neuonc/noae051
Published: 08 April 2024
Journal Article

ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma

PDF
Isabel Arrillaga-Romany and others
Neuro-Oncology, Volume 26, Issue Supplement_2, April 2024, Pages S173–S181, https://doi.org/10.1093/neuonc/noae031
Published: 06 March 2024
Journal Article

Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort

PDF
Yazmin Odia and others
Neuro-Oncology, Volume 26, Issue Supplement_2, April 2024, Pages S165–S172, https://doi.org/10.1093/neuonc/noae021
Published: 22 February 2024
Journal Article

Diffuse midline glioma, H3K27-altered: Illuminating the dark side of the moon

PDF
Matthew D Dun and others
Neuro-Oncology, Volume 26, Issue Supplement_2, April 2024, Pages S89–S91, https://doi.org/10.1093/neuonc/noad245
Published: 18 December 2023
Journal Article

TMET-02. CLINICAL EFFICACY OF ONC201 IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMAS IS DRIVEN BY DISRUPTION OF INTEGRATED METABOLIC AND EPIGENETIC PATHWAYS

PDF
Sriram Venneti and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v272, https://doi.org/10.1093/neuonc/noad179.1046
Published: 10 November 2023
Journal Article

CTNI-47. DOSE ESCALATION OF ASTX727 IN ADULT PATIENTS WITH RECURRENT/PROGRESSIVE NON-ENHANCING IDH MUTANT GLIOMAS

PDF
Isabel Arrillaga-Romany and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v85–v86, https://doi.org/10.1093/neuonc/noad179.0329
Published: 10 November 2023
Journal Article

CTNI-17. APPLICATION OF THE GBM-X DATA PLATFORM TO ESTIMATE TREATMENT EFFECTS OF THE EXPERIMENTAL THERAPIES OF THE RANDOMIZED PHASE 2 INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPIES

PDF
Rifaquat Rahman and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v76–v77, https://doi.org/10.1093/neuonc/noad179.0299
Published: 10 November 2023
Journal Article

CTIM-14. PHASE 1 SAFETY LEAD-IN AND RANDOMIZED OPEN-LABEL PERIOPERATIVE STUDY OF VORASIDENIB COMBINED WITH PEMBROLIZUMAB IN RECURRENT OR PROGRESSIVE ENHANCING IDH1-MUTANT ASTROCYTOMAS: SAFETY LEAD-IN RESULTS

PDF
Patrick Wen and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v64, https://doi.org/10.1093/neuonc/noad179.0254
Published: 10 November 2023
Journal Article

CTIM-38. NEUROTOXICITY AND MANAGEMENT OF PRIMARY AND SECONDARY CNS LYMPHOMA AFTER ADOPTIVE IMMUNOTHERAPY WITH CD19-DIRECTED CAR T-CELLS

PDF
Philipp Karschnia and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v71, https://doi.org/10.1093/neuonc/noad179.0278
Published: 10 November 2023
Journal Article

CTIM-37. A PILOT STUDY OF AXICABTAGENE CILOLEUCEL (AXI-CEL) FOR THE TREATMENT OF RELAPSED/REFRACTORY PRIMARY AND SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL AND SCNSL)

PDF
Lakshmi Nayak and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v71, https://doi.org/10.1093/neuonc/noad179.0277
Published: 10 November 2023
Journal Article

NCOG-34. BRAIN PET IMAGING OF PAIRED HELICAL FILAMENT TAU IN OLDER ADULTS WITH CANCER: PILOT STUDY TO IDENTIFY MECHANISMS OF COGNITIVE IMPAIRMENT AFTER CANCER THERAPY

PDF
Michael Parsons and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v221, https://doi.org/10.1093/neuonc/noad179.0847
Published: 10 November 2023
Journal Article

DIPG-08. THE LANDSCAPE OF TUMOR CELL STATES AND SPATIAL ORGANIZATION IN H3-K27M MUTANT DIFFUSE MIDLINE GLIOMA ACROSS AGE AND LOCATION

PDF
Ilon Liu and others
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i14, https://doi.org/10.1093/neuonc/noad073.055
Published: 12 June 2023
Journal Article

IDH-mutant glioma: A new IDH1 inhibitor moves forward

PDF
Julie J Miller and Isabel Arrillaga-Romany
Neuro-Oncology, Volume 25, Issue 2, February 2023, Pages 337–338, https://doi.org/10.1093/neuonc/noac275
Published: 16 December 2022